Review
Copyright ©The Author(s) 2023.
World J Gastroenterol. Feb 21, 2023; 29(7): 1139-1156
Published online Feb 21, 2023. doi: 10.3748/wjg.v29.i7.1139
Table 1 Studies of Telemonitoring in inflammatory bowel disease
Ref.
Disease
Type of study
n
Application
Outcomes
Cross et al[21]IBDNoncontrolled, clinical trial10Telemonitoring, home unit-server PC providerFeasible method
Excellent patient acceptance
Cross et al[113]IBDNoncontrolled clinical trial25Telemonitoring, home unit-server PC providerFeasible method
Excellent patient acceptance
Improvement in QoL, disease activity, and disease knowledge
Cross et al[42]UCControlled randomized clinical trial47Telemonitoring, home unit-server PC providerFeasible method
Excellent patient acceptance
Improvement in QoL
Elkjaer et al[115]UCValidation study in 2 groups21Telemonitoring through the webFeasible method
Excellent patient acceptance
Elkjaer et al[22]UCControlled randomized clinical trial333Telemonitoring through the webFeasible method
Excellent patient acceptance
Improvement in QoL, disease knowledge, and adherence
Pedersen et al[10]CDPilot study, controlled 27Telemonitoring through the webFeasible and safe method for individualized scheduling of maintenance IFX treatment
Pedersen et al[11]UCProspective noncontrolled study95Telemonitoring through the webFeasible and improve adherence to therapy
Torrejón et al[56]IBDDescriptive, observational, retrospective1784Telecare through e-mail, phone calls, faxIncreased telematic contacts and decreased in-person care
Johnson et al[27]IBDTelemonitoring project420A web-guided programmeEffective, safe and cost savings
De Jong et al[24]IBDControlled randomized clinical trial909Telemonitoring through the web (mHealth)Reduced outpatient visits and hospitalizations
Carlsen et al[43]IBDControlled randomized clinical trial53Telemonitoring through the web (mHealth)Reduced outpatient visits
No differences in disease activity, QoL or adherence compared with standard care
Walsh et al[112]UCPilot study, non controlled66Telemonitoring through the web (mHealth)Feasible and usable to measure disease activity, QoL and medication use
Del Hoyo et al[52]IBDControlled randomized clinical trial63Telemonitoring through the webHigher improvement in disease activity compared to usual care
Similar improvement in QoL, social activities and satisfaction between groups
Cross et al[25]IBDControlled randomized clinical trial348Telemonitoring through the web (mHealth)Improvement in disease activity and QoL, although not superior to usual care
Decrease in hospitalizations and increase in distance contacts
Bilgrami et al[48]IBDControlled randomized clinical trial222Telemonitoring through the web (mHealth)No differences in self-efficacy or patient activation compared with standard care
Schliep et al[47]IBDControlled randomized clinical trial217Telemonitoring through the web (mHealth)No significant improvement in depressive symptoms or QoL compared with standard care
Heida et al[45]IBDControlled randomized clinical trial170Telemonitoring through the web, e-mail and telephoneSimilar improvement in QoL compared to conventional care
Reduction in outpatient visits and societal costs
Satisfaction
Linn et al[46]IBDControlled randomized clinical trial160Telemonitoring through the web or SMS combined with tailored counsellingImproved self-efficacy
Satisfaction
Bonnaud et al[51]IBDControlled randomized clinical trial54Telemonitoring through the web (mHealth)Significant improvement in QoL
A trend to reduce outpatient visits
Satisfaction
McCombie et al[50]IBDControlled randomized clinical trial100Telemonitoring through the web (mHealth) and home-based FCNon-inferiority of QoL and symptoms
Reduced outpatient visits